Table I.
The clinicopathological characteristics of epidermal growth factor receptor (EGFR) and p53.
| EGFR | p53 | |||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| Positive (%) | Negative (%) | p-value | Positive (%) | Negative (%) | p-value | |
| Age (years) | 1.000 | 1.000 | ||||
| <50 | 17 (68.0) | 8 (32.0) | 21 (84.0) | 4 (16.0) | ||
| ≥50 | 13 (72.2) | 5 (27.2) | 15 (83.3) | 3 (16.7) | ||
| Gender | 0.307 | 0.229 | ||||
| Male | 13 (81.3) | 3 (18.7) | 15 (93.4) | 1 (6.6) | ||
| Female | 17 (63.0) | 10 (37.0) | 21 (77.8) | 6 (22.2) | ||
| Myasthenia gravis | 0.727 | 0.652 | ||||
| Positive | 9 (75.0) | 3 (25.0) | 11 (91.6) | 1 (8.4) | ||
| Negative | 21 (67.7) | 10 (22.3) | 25 (80.7) | 6 (29.3) | ||
| Tumor size (cm) | 0.011 | 0.082 | ||||
| <6 | 8 (47.1) | 9 (53.9) | 11 (68.8) | 5 (31.2) | ||
| ≥6 | 22 (84.6) | 4 (15.4) | 25 (92.6) | 2 (7.4) | ||
| Histology | 0.001 | 0.030 | ||||
| Thymoma | 30 (70.0) | 13 (30.0) | 37 (86.0) | 6 (14.0) | ||
| Thymus hyperplasia | 3 (18.8) | 13 (81.2) | 9 (56.3) | 7 (43.7) | ||